The Department of Health and Human Services submitted an interim access policy for peptide compounding to the White House Office of Management and Budget on October 15, 2026

From the articleTrump Administration Advances Plan for Peptides Favored by RFK Jr.Also in Trump administration advances plan for peptide drugs favored by RFK Jr., US FDA takes step to change peptide compounding policy | Reuters